Soluble suppression of tumorigenicity-2 changes during cardiotoxic cancer treatment: a systematic review and meta-analysis
sST2 showed dynamic changes during cardiotoxic therapy correlating with cardiotoxicity. Troponin was demonstrated to have greater longitudinal variations. Further research is needed to evaluate longitudinal sST2 levels in patients who develop cardiotoxicity vs. those who do not.
Authors
- L Pascalis
- Luca Fazzini (ORCID: https://orcid.org/0000-0003-2407-7435)
- Pietro Ameri (ORCID: https://orcid.org/0000-0001-7167-7287)
- Nicola Campana (ORCID: https://orcid.org/0000-0001-6876-5083)
- Carlo G. Tocchetti (ORCID: https://orcid.org/0000-0001-5983-688X)
- Vincenzo Quagliariello
- Nicola Maurea (ORCID: https://orcid.org/0000-0003-3704-0092)
- Martino Deidda (ORCID: https://orcid.org/0000-0002-3725-7614)
- Simone Angius
- Giordano Maria Pugliesi (ORCID: https://orcid.org/0009-0008-6770-1414)
- Christian Cadeddu Dessalvi
Institutions
- University of Cagliari (IT)
- Federico II University Hospital (IT)
- Mayo Clinic in Arizona (US)
- Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" (IT)
- Ospedale Policlinico San Martino (IT)
- University of Milano-Bicocca (IT)
- University of Genoa (IT)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2025-11-11
- DOI
- https://doi.org/10.3389/fcvm.2025.1624023
- Citations
- 1
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- European Commission